NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

13 hedge funds and large institutions have $286K invested in Northwest Biotherapeutics, Inc. Common stock in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MSAM
1
Moloney Securities Asset Management
Missouri
$181K
2
LDB
2
Lee, Danner & Bass
Tennessee
$9K
3
SL
3
Sentinus LLC
Illinois
$5.52K
4
KA
4
KLCM Advisors
Wisconsin
$4.27K

Top Sellers

1
WJWM
1
Williams Jones Wealth Management
New York
$14.9K
Name Market Value Shares Shares
Change 		Shares
Change %
MSAM
1
Moloney Securities Asset Management
Missouri
$181K 424,310 +44,850 +12%
OCG
2
Opus Capital Group
Ohio
$26K 60,150 – –
MWM
3
Maripau Wealth Management
Indiana
$16.9K 39,493 – –
WJWM
4
Williams Jones Wealth Management
New York
$14.9K 35,000 -5,000 -13%
EFG
5
Ethos Financial Group
Pennsylvania
$10K 23,700 – –
LDB
6
Lee, Danner & Bass
Tennessee
$9K 20,000 +20,000 New
MCM
7
MAI Capital Management
Ohio
$8.54K 20,000 – –
AA
8
AlphaMark Advisors
Kentucky
$6K 14,007 – –
SL
9
Sentinus LLC
Illinois
$5.52K 12,925 +12,925 New
KA
10
KLCM Advisors
Wisconsin
$4.27K 10,000 +10,000 New
AMG
11
Advisors Management Group
Wisconsin
$4K 10,270 – –
HFS
12
Hantz Financial Services
Michigan
$0 250 – –
CMP
13
Coston McIsaac & Partners
Maine
$0 1,000 – –